Amgen Inc. buy Scotiabank
Start price
13.11.25
/
50%
€292.00
Target price
13.11.26
€332.22
Performance (%)
5.58%
Price
27.03.26
€303.40
Summary
This prediction is currently active. With a performance of 5.58%, the BUY prediction by Scotiabank for Amgen Inc. is trending in the right direction. Dividends of €4.90 are taken into consideration when calculating the performance. This prediction currently runs until 13.11.26. The prediction end date can be changed by Scotiabank at any time. Scotiabank has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 0.747% | 0.747% |
| iShares Core DAX® | -0.479% | -12.062% |
| iShares Nasdaq 100 | -3.377% | -5.130% |
| iShares Nikkei 225® | -0.143% | -12.633% |
| iShares S&P 500 | -2.266% | -5.049% |
Comments by Scotiabank for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) is now covered by analysts at Scotiabank. They set an "outperform" rating and a $385.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat